Monitoring response to anti-angiogenic mTOR inhibitor therapy in vivo using 111In-bevacizumab
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2191-219X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Monitoring response to anti-angiogenic mTOR inhibitor therapy in vivo using 111In-bevacizumab ; volume:7 ; number:1 ; day:30 ; month:5 ; year:2017 ; pages:1-9 ; date:12.2017
EJNMMI Research ; 7, Heft 1 (30.5.2017), 1-9, 12.2017
- Schlagwort
-
Krebs
Onkologie
- Urheber
-
Patel, Neel
- Beteiligte Personen und Organisationen
-
Able, Sarah
Allen, Danny
Fokas, Emmanouil
Cornelissen, Bart
Gleeson, Fergus V.
Harris, Adrian L.
Vallis, Katherine A.
SpringerLink (Online service)
- DOI
-
10.1186/s13550-017-0297-9
- URN
-
urn:nbn:de:1111-201706237227
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.01.0008, 06:25 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Patel, Neel
- Able, Sarah
- Allen, Danny
- Fokas, Emmanouil
- Cornelissen, Bart
- Gleeson, Fergus V.
- Harris, Adrian L.
- Vallis, Katherine A.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Enhancing the anti-angiogenic action of histone deacetylase inhibitors
Anti-angiogenic alternatives to VEGF blockade
Anti-angiogenic therapies in brain metastases
Future options of anti-angiogenic cancer therapy
Correction: Beyond starving cancer: anti-angiogenic therapy
An intuitionistic approach for the predictability of anti-angiogenic inhibitors in cancer diagnosis
Therapeutic effects of axitinib, an anti-angiogenic tyrosine kinase inhibitor, on interstitial cystitis
Characterization of anti-angiogenic therapy response in glioblastoma
Anti-angiogenic therapies for advanced esophago-gastric cancer
Perforated Gastric Ulcer Associated with Anti-Angiogenic Therapy
Anti-angiogenic SPARC peptides inhibit progression of neuroblastoma tumors
Proteomic analysis predicts anti-angiogenic resistance in recurred glioblastoma
Enhancing the anti-angiogenic action of histone deacetylase inhibitors
Anti-angiogenic alternatives to VEGF blockade
Anti-angiogenic therapies in brain metastases
Future options of anti-angiogenic cancer therapy
Correction: Beyond starving cancer: anti-angiogenic therapy
An intuitionistic approach for the predictability of anti-angiogenic inhibitors in cancer diagnosis
Therapeutic effects of axitinib, an anti-angiogenic tyrosine kinase inhibitor, on interstitial cystitis
Characterization of anti-angiogenic therapy response in glioblastoma
Anti-angiogenic therapies for advanced esophago-gastric cancer
Perforated Gastric Ulcer Associated with Anti-Angiogenic Therapy
Anti-angiogenic SPARC peptides inhibit progression of neuroblastoma tumors
Proteomic analysis predicts anti-angiogenic resistance in recurred glioblastoma
Enhancing the anti-angiogenic action of histone deacetylase inhibitors
Anti-angiogenic alternatives to VEGF blockade
Anti-angiogenic therapies in brain metastases
Future options of anti-angiogenic cancer therapy
Correction: Beyond starving cancer: anti-angiogenic therapy
An intuitionistic approach for the predictability of anti-angiogenic inhibitors in cancer diagnosis
Therapeutic effects of axitinib, an anti-angiogenic tyrosine kinase inhibitor, on interstitial cystitis
Characterization of anti-angiogenic therapy response in glioblastoma
Anti-angiogenic therapies for advanced esophago-gastric cancer
Perforated Gastric Ulcer Associated with Anti-Angiogenic Therapy
Anti-angiogenic SPARC peptides inhibit progression of neuroblastoma tumors